Related references
Note: Only part of the references are listed.Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer
Ozan Yazici et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2021)
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
Angela Dalia Ricci et al.
CANCERS (2021)
Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential
Chu-Fang Chou et al.
CANCER INVESTIGATION (2021)
Osteopontin drives KRAS-mutant lung adenocarcinoma
Ioanna Giopanou et al.
CARCINOGENESIS (2020)
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
Eric C. Cheung et al.
CANCER CELL (2020)
Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5-CD44+ cells
Dah-Jiun Fu et al.
NATURE COMMUNICATIONS (2020)
Challenges in the treatment of gastric cancer in the older patient
Nalinie Joharatnam-Hogan et al.
CANCER TREATMENT REVIEWS (2020)
Tumour predisposition and cancer syndromes as models to study gene-environment interactions
Michele Carbone et al.
NATURE REVIEWS CANCER (2020)
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight
Anne-Sophie Lamort et al.
CELLS (2019)
Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin
Jean Chiou et al.
CANCER RESEARCH (2019)
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
Lian-Jiu Su et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase
Chengcheng Hao et al.
SCIENTIFIC REPORTS (2019)
Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
Kinga Walaszek et al.
BRITISH JOURNAL OF CANCER (2018)
Reactive oxygen species and cancer paradox: To promote or to suppress?
Sehamuddin Galadari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
ROS-modulated therapeutic approaches in cancer treatment
Muhammad Hassan Raza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
The Roles of ROS in Cancer Heterogeneity and Therapy
Paulo Luiz de Sa Junior et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma
Ning Gan et al.
JOURNAL OF CANCER (2017)
Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues
Ana Clara Santos Fonseca Bastos et al.
CANCER LETTERS (2017)
Osteopontin splice variants and polymorphisms in cancer progression and prognosis
Marco Antonio Briones-Orta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells
K. D. M. Nakamura et al.
TUMOR BIOLOGY (2016)
Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
Jules Lin et al.
ONCOTARGET (2015)
Osteopontin as a therapeutic target for cancer
Monalisa Bandopadhyay et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Osteopontin Splice Variants Differentially Exert Clinicopathological Features and Biological Functions in Gastric Cancer
Xiaojian Tang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Antje Hahnel et al.
BMC CANCER (2012)
Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway
Xianmin Luo et al.
MOLECULAR CANCER RESEARCH (2011)
Pre- and post-translational regulation of osteopontin in cancer
Pieter H. Anborgh et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2011)
Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
Meghan B. Azad et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines
Sujin Chae et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
Chun-Ying Wu et al.
GUT (2007)
An osteopontin splice variant induces anchorage independence in human breast cancer cells
B He et al.
ONCOGENE (2006)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
Electrical wound-healing assay for cells in vitro
CR Keese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
